Studies with live attenuated influenza virus in chronic bronchitis.
The use of live, recombinant virus for immunisation against influenza produced a number of respiratory illnesses, some severe, in patients with chronic obstructive airways disease. These patients are probably more susceptible to the influenza virus than are normal subjects. Special care will be needed in testing these viruses on patients with respiratory disease.
D000368:Aged; D001991:Bronchitis / Q000150:complications / Q000276:immunology*; D002908:Chronic Disease; D006801:Humans; D007114:Immunization; D009980:Influenza A virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000009:adverse effects*; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000209:etiology*; D014613:Vaccines, Attenuated / Q000009:adverse effects*
D007252:Influenza Vaccines; D014613:Vaccines, Attenuated